Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Evaluation of algorithm development approaches: Development of biomarker panels for early detection of colorectal lesions

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Reference values for leptin/adiponectin ratio in healthy children and adolescents

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Clinical proteomics: Insights from IGF-I

    Research output: Contribution to journalReviewResearchpeer-review

  4. Validation of image cytometry for sperm concentration measurement: Comparison with manual counting of 4010 human semen samples

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Clinical usefulness of bone turnover marker concentrations in osteoporosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Cell free DNA (cfDNA) has shown promising utility as prognostic biomarker for patients with colorectal cancer (CRC), with an ongoing need to optimize and validate the laboratory methodology. Here, we report our optimization and validation of a direct fluorescent assay and display the potential utility in patients with colorectal cancer.

METHODS: Plasma cfDNA was analyzed by a direct fluorescent assay (DFA) and compared to quantification by droplet digital PCR (ddPCR). For clinical validation, baseline blood samples were available for a total of 273 patients from six different Nordic trials, covering patients with locally advanced rectal cancer (n = 176, cohorts A + B), liver limited metastatic CRC (n = 75C + D) and wide spread metastatic CRC (n = 22 E + F).

RESULTS: Validating the DFA analysis with ddPCR revealed a strong correlation with an R2 of 0.81. For the clinical cohorts, the levels of cfDNA were: 0.8 ng/uL (95%CI 0.75-0.83) (A + B), 0.93 ng/uL (95%CI 0.86-1.02) (C + D) and 1.2 ng/uL (95%CI 0.85-1.47) (E + F), respectively (p < 0.01). All cohorts of colorectal cancer had higher levels of cell free DNA than healthy individuals (n = 94) (p < 0.01).

CONCLUSION: Analysis of cell free DNA by a direct fluorescent assay could be an attractive laboratory option for a rapid inexpensive quantification of cell free DNA.

Original languageEnglish
JournalClinica chimica acta; international journal of clinical chemistry
Volume487
Pages (from-to)107-111
Number of pages5
ISSN0009-8981
DOIs
Publication statusPublished - Dec 2018

ID: 56671010